REGULATORY

• Japan Cabinet OKs Bill to Allow Govt to Declare Emergency over Coronavirus
  March 11, 2020

• Japan Govt Orders 20,000 Alvesco Inhalers as Coronavirus Measure
  March 11, 2020

• Japan Sets 1st Rollout of Amended PMD Law for Sept. 1
  March 9, 2020

• PMDA Reviewing Safety Risks for Xofluza, Keytruda
  March 9, 2020

• Japan Starts Health Coverage for COVID-19 Testing
  March 6, 2020

• 7 Generic API Specifications Subject to New Rule to Address Unreasonable Price Rises
  March 6, 2020

• 3 Drugs Earn Post-Launch “True Clinical Utility” Premium; Forxiga Price Flat, Rises for Canaglu and Praluent
  March 5, 2020

• Price Maintenance Premium Granted to 335 APIs/555 Products; Novartis Top PMP Earner
  March 5, 2020

• With 80%-Plus Gx Rates, Many One-Time Blockbusters Might Be In for Earlier “G1” Price Cuts
  March 5, 2020

• Xolair Faces 37.3% Price Slash, Keytruda 20.9% in April: MHLW
  March 5, 2020

• MHLW Orders Package Insert Revisions to Eliminate Vaccination Interval Restriction
  March 5, 2020

• Sandostatin Now Eligible for Health Coverage for Congenital Hyperinsulinemia
  March 4, 2020

• Japan Mulling Legal Preparations to Declare State of Emergency over Coronavirus
  March 4, 2020

• Japan Panel Says No to Nonprescription Switch for Domperidone, Menatetrenone; Decision Now Up for Public Comments
  March 3, 2020

• MHLW to Announce New NHI Prices on March 5
  March 3, 2020

• Senior Vice Health Minister, Parliamentary Secretary Test Negative for Coronavirus
  March 3, 2020

• MHLW Panel Clears Latuda, 1st Japan-Originated Oligonucleotide; Approval Expected in March
  March 2, 2020

• Daiichi Sankyo’s Enhertu Clears MHLW Panel, Conditional Nod Expected in March
  February 27, 2020

• Rust in Needles in Sanofi’s ActHIB “Occurred Accidentally,” Supplies to Resume: MHLW
  February 27, 2020

• Zolgensma Now in Line for Japan Approval in March, All Eyes Now Riveted on Price
  February 27, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 183
• 184
• 185
• 186
• 187
• 188
• 189
• 190
• 191
• …
• Next ›
• 最終 »